INSULIN Act
- Nov 17Shaheen highlighted health advocacy support for bipartisan INSULIN Act to cap insulin costs at $35 monthly.
- Nov 17Shaheen pushed for bipartisan INSULIN Act passage to cap monthly insulin costs at $35.
Issues / Issue · Oct 22 – Nov 20, 2026
| Action type | Wk ofOct 222 | Wk ofOct 292 | Wk ofNov 52 | Wk ofNov 129 | Wk ofNov 192 | Total |
|---|---|---|---|---|---|---|
| Sent lettersTo agencies, companies, officials | 3 | |||||
| HearingsHeld, testified or questioned | 5 | |||||
| CriticizedA policy, decision or person | 1 | |||||
| PraisedCredit for a decision or person | 1 | |||||
| Filed or pushed billsNew, reintroduced or passed | 5 | |||||
| Other | 2 |
Actions each member took in this window
Actions by members from each state, split by party. A joint release counts once for each member on it.
+4 more with fewer actions
Recognitions and tributes not counted.
Introduced bill to lower prescription drug costs by expanding access to biosimilars.
DShaheen NH $200M
Led 243 lawmakers urging reauthorization of Special Diabetes Program before December 31 expiration.
Pushed for bipartisan INSULIN Act passage to cap monthly insulin costs at $35.
Highlighted health advocacy support for bipartisan INSULIN Act to cap insulin costs at $35 monthly.
Opposed FDA nominee Heidi Overton's confirmation, citing anti-abortion extremism and medication abortion stance.
Held hearing examining competition and transparency to lower prescription drug costs.
Called for passage of bipartisan Drug-price Transparency for Consumers Act during Senate Judiciary Committee hearing.
Questioned witnesses about Medicare's authority to negotiate prescription drug costs during Senate Judiciary Committee hearing.
Chaired hearing on prescription drug costs and bipartisan bills to lower prices.
Warned against prediction markets allowing betting on clinical trials and drug approvals.
Introduced bipartisan bill to preserve prescription drug discounts for safety-net providers.
Praised Department of Labor rule requiring pharmacy benefit managers to disclose fees.
Introduced bipartisan bill to protect patient access to affordable medications through 340B program.
Introduced bipartisan bill to expand Medicare drug subsidy eligibility to Puerto Rico.
Urged FTC to complete pharmacy benefit manager investigation and release final recommendations.
Summaries, action types, amounts and positions are read from each press release by AI and can be wrong. Joint releases (same day, same action, matching title or amount) count once. How it works